Involvement of orexigenic peptides in the mechanism of gastric mucosal integrity and healing of chronic gastric ulcers

Current Pharmaceutical Design

Volumn 16, Issue 10, 2010, Pages 1214-1223

  Szlachcic, Aleksandra ^a   Brzozowski, Thomas ^a   Majka, Jolanta ^a   Pajdo, Robert ^a   Konturek, Peter C ^b   Pawlik, Michal ^a   Kwiecien, Slawomir ^a   Drozdowicz, Danuta ^a   Bielanski, Wladyslaw ^a   Konturek, Stanislaw J ^a   Pawlik, Wieslaw W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Gastric blood flow; Ghrelin; Obestatin; Orexin A; Prostaglandin; Ulcer healing

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETIC ACID; ACETYLSALICYLIC ACID; APPETITE STIMULANT; BETA ACTIN; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GASTRIN; GHRELIN; GHRELIN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OBESTATIN; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; ROFECOXIB; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; DRUG RESEARCH; FOOD INTAKE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPEREMIA; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STOMACH BLOOD FLOW; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STOMACH ULCER; ULCER HEALING; VAGUS TONE;

ANIMALS; APPETITE STIMULANTS; CYCLOOXYGENASE 2 INHIBITORS; GASTRIC MUCOSA; GHRELIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RATS; STOMACH ULCER;

EID: 77950906564     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790945940     Document Type: Review

References (51)

1. Konturek PK, Brzozowski T, Konturek SJ, Dembinski A. Role of epidermal growth factor, prostaglandin and sulfhydryls in stress-induced gastric lesions. Gastroenterology 1990; 99: 1607-1615 (Pubitemid 20162288)
2. Li YM, Lu GM, Zou XP, Li ZS, Peng GY, Fang DC. Dynamic functional and ultra structural changes of gastric parietal cells induced by water immersion-restraint stress in rats. World J Gastroenterol 2006; 12: 3368-3372
3. Kwiecien S, Pawlik MW, Sliwowski Z, Kwiecien N, Brzozowski T, Pawlik WW, et al. Involvement of sensory afferent fibers and lipid peroxidation in the pathogenesis of stress-induced gastric mucosa damage. J Physiol Pharmacol 2007; 58 (Suppl 3): 149-162 (Pubitemid 47523112)
4. Kojima M, Hosoda H, Date Y, Nakazo M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660 (Pubitemid 129516334)
5. Tomasetto C, Karam SM, Ribieras S, Masson R, Lefebvre O, Staub A, et al. Identification and characterization of a novel gastric peptide hormone; the motilin-related peptide. Gastroenterology 2000; 119: 395-405. (Pubitemid 30621990)
6. Tschop M, Smiley DL, Heiman M. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913
7. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 2001; 280: 904-907 (Pubitemid 32924518)
8. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 267: 905-958
9. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-4758 (Pubitemid 33020516)
10. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, et al. Appetite encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999
11. Peeters TL. Ghrelin: a new player in the control of gastrointestinal functions. Gut 2005; 54: 1638-1649 (Pubitemid 41531785)
12. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and desacyl ghrelin: two major forms of rat ghrelin peptide in gastro-intestinal tissue. Biochem Bioph Res Commun 2000; 281: 1220-1225 (Pubitemid 32042875)
13. Chemeli RM, Tanaka H, Williams SC, Rickson JA, Kozlowski GP, Wilson S. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behaviour. Cell 1998; 92: 573-585
14. de Lecea L, Kilduff TS, Peyron C, Gao X-B, Foye PE, Danielson PE, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322-327
15. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell 1998; 92: 573-585
16. Kirchgessner AL, Liu M-T. Orexin synthesis and response in the gut. Neuron 1999; 24: 941-951
17. Komaki G, Matsumoto Y, Nishikata H, Kawai K, Nozaki T, Takii M, et al. Orexin-A and leptin change inversely in fasting non-obese subjects. Eur J Endocrinol 2001; 144: 645-651
18. Sibilia V, Rindi G, Pagani F, Rapetti D, Locatelli V, Torsello A, et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144: 353-359
19. Brzozowski T, Konturek PC, Konturek SJ, Kwiecien S, Drozdowicz D, Bielanski W, et al. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Reg Pept 2004; 120: 39-51.
20. Konturek PC, Brzozowski T, Pajdo R, Nikiforuk A, Kwiecien S, Harsch I, et al. Ghrelin - a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55: 325-336
21. Brzozowski T, Konturek PC, Sliwowski Z, Pajdo R, Drozdowicz D, Kwiecien S, et al. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharm Exp Ther 2006; 319: 447-487
22. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607-611 (Pubitemid 20069172)
23. Lugarini F, Hrupka BJ, Schwartz GJ, Plata-Salaman CR, Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia nervosa in rats. Am J Physiol 2002; 283: R862-8.
24. Scholz H. Prostaglandins. Am J Physiol 2003; 285: R512-4.
25. Eberhart CE, Dubois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995; 109: 285-301.
26. Davies NM, Sharkley KA, Asfaha S, MacNaughton WK, Wallace JL. Aspirin causes rapid up-regulation of cyclooxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997; 11: 1101-1108 (Pubitemid 27525102)
27. Lesch CA, Gilbertsen RB, Song Y, Dyer RD, Sehrier D, Kraus ER, et al. Effect of novel anti-inflammatory compounds on healing of acetic acid--induced gastric ulcer in rats. J Pharm Exp Ther 1998; 287: 301-306 (Pubitemid 29140214)
28. Tanaka A, Hase S, Miyazawa T, Takeuchi K. Roles of COX-1 and COX-2 inhibition in nonsteroidal antiinflammatory drug-induced gastric damage in rats: Relation to functional responses. Aliment Pharmacol Ther 2002; 16: 90-101.
29. Takeuchi K, Tanaka A, Hayashi Y, Kubo Y. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility. Dig Dis Sci 2004; 49: 180-187 (Pubitemid 38392215)
30. Brzozowski T, Konturek PC, Konturek SJ, Pierzchalski P, Bielanski W, Pajdo R, et al. Central leptin and cholecystokinin in gastroprotection against ethanol-induced damage. Digestion 2000; 62: 126-142
31. Brzozowski T, Konturek PC, Sliwowski Z, Drozdowicz D, Burnat G, Pajdo R, et al. Gastroprotective action of orexin-A against stress-induced gastric damage is mediated by endogenous prostaglandins, sensory afferent neuropeptides and nitric oxide. Reg Pept 2008; 148: 6-20.
32. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761-767
33. Kwiecien S, Brzozowski T, Konturek PC, Konturek SJ, Pawlik M, Pajdo R, et al. Effect of central and peripheral actions of histamine and its metabolite N-alpha methyl histamine on gastric secretion and acute gastric lesions. J Physiol Pharmacol 2001; 52: 625-638 (Pubitemid 34164751)
34. Konturek SJ, Stachura J, Radecki T, Drozdowicz D, Brzozowski T. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats. Digestion 1987; 38: 103-113 (Pubitemid 18002247)
35. Brzozowski T, Konturek SJ, Sliwowski Z, Pytko-Polonczyk J, Sclachcic A, Drozdowicz D, et al. Role of capsaicin-sensitive sensory nerves in gastroprotection against acid-independent and acid-dependent ulcerogens. Digestion 1996; 57: 424-432 (Pubitemid 26385294)
36. Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 2008; 143: 334-342
37. Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D, et al. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Techn 2001; 53: 343-353 (Pubitemid 32494584)
38. Okabe S, Pfeiffer CJ, Roth JLA. A method for experimental penetrating gastric and duodenal ulcers in rats. Digestion 1987; 38: 103-113
39. Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA, et al. SB-334867: the first selective orexin-1 receptor antagonist. Br J Pharmacol 2001; 132: 1179-1189 (Pubitemid 32234700)
40. Holland PR, Akerman S, Goadsby PJ. Modulation of nociceptive dural intput to the trigeminal nucleus caudal is via activation of the orexin1 receptor in the rat. Eur J Neurosci 2006; 24: 2825-2833
41. Sibilia V, Torsello A, Pagani F, Rapetti D, Lattuada N, Bocatelli V, et al. Effects of hexarelin against acid-independent and aciddependent ulcerogens in the rat. Peptides 2004; 25: 2163-2170 (Pubitemid 39574459)
42. Sibillia V, Bresciani E, Lattuada N, Lattuada N, Rapetti D, Locatelli V. Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J Endocrinol Invest 2006; 29: 31-34 (Pubitemid 46344225)
43. Lagaud GJ, Young A, Ascena A, Morton MF, Barrett TD, Shankley NP. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 2007; 357: 264-269 (Pubitemid 46574526)
44. Moechrs D, Depoortere I, Moreaux B, de Smet B, Goris I, Hoskens L. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 2006; 131: 1131-1141 (Pubitemid 44498686)
45. Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007; 148: 21-26 (Pubitemid 46021434)
46. Tremblay F, Perreault M, Klaman LD, Tobin JF, Smith E, Gimeno RE. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 2007; 148: 501-506 (Pubitemid 46143155)
47. Zizzari P, Longschamps R, Epelbaum J, Bluet-Pajot MTA. Obestatin partially affects ghrelin stimulation of food intake and GH secretion in rodents. Endocrinology 2007; 148: 1648-1653 (Pubitemid 46457120)
48. Fukuhara S, Suzuki H, Masaoka T, Arakawa M, Hosoda H, Minegishi Y, et al. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. Am J Physiol 2005; 289: 139-145
49. Bernard MP, Bancos S, Sime PJ, Phipps RP. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise. Curr Pharm Des 2008; 14(21): 2051-2060
50. Dogne JM, Thiry A, Supuran CT. Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs. Curr Pharm Des 2008; 14(7): 679-684
51. Hanai H, Sugimoto K. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 2009; 15(18): 2087-2094